| bibliographicCitation |
Mattei P, Boehringer M, Di Giorgio P, Fischer H, Hennig M, Huwyler J, Koçer B, Kuhn B, Loeffler BM, MacDonald A, Narquizian R, Rauber E, Sebokova E, Sprecher U. Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 2010 Feb;20(3):1109–13. doi: 10.1016/j.bmcl.2009.12.024. |